OBJECTIVE -We evaluated the role of a single measurement of HbA 1c in a diabetes case finding in hospitalized patients with random hyperglycemia at admission.
RESEARCH DESIGN AND METHODS -From 20March to 31 July 2000, 508 patients admitted through the emergency department of one hospital were tested for random hyperglycemia (plasma glucose [PG] Ͼ125 mg/dl). Consenting patients with hyperglycemia (without preexisting diabetes or on corticosteroids) underwent testing for HbA 1c levels, two fasting PG levels, and an outpatient oral glucose tolerance test (OGTT) if necessary.RESULTS -Of the patients, 50 (9.8%) met the inclusion criteria. Of these, 70% (n ϭ 35) completed the study, and 60% (n ϭ 21) were diagnosed with diabetes. Patients with diabetes had higher HbA 1c levels than subjects without diabetes (6.8 Ϯ 0.4 vs. 5.3 Ϯ 0.1%, P ϭ 0.002). An HbA 1c level Ͼ6.0% was 100% specific (14/14) and 57% sensitive (12/21) for the diagnosis of diabetes. When a lower cutoff value of HbA 1c at 5.2% was used, specificity was 50% (10/21) and sensitivity was 100% (7/14). CONCLUSIONS -In acutely ill patients with random hyperglycemia at hospital admission, an HbA 1c Ͼ6.0% reliably diagnoses diabetes, and an HbA 1c level Ͻ5.2% reliably excludes it (paralleling the operating characteristics of the standard fasting glucose measurements); however, the rapidity of the HbA 1c level can be useful for diabetes case finding and treatment initiation early in the hospital course.
Data from this pilot program suggest that the immersive, virtual teaching method is well suited to team-based, reflective practice and learning of disaster management skills.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.